AstraZeneca’s Baxdrostat Shows Strong Phase III Re...
Category : Clinical Trial Update 6 January 2026AstraZeneca has reported encouraging phase III clinical data for baxdrostat, a first-in-class oral a...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
GenEditBio Secures US FDA IND Clearance for First-...
Category : Clinical Trial Update 6 January 2026The US Food and Drug Administration has cleared the IND application for GEB-101, enabling the compan...
Delova Reports Positive Phase 3 Results for Long-A...
Category : Clinical Trial Update 6 January 2026Nanjing Delova has cleared a major clinical hurdle in postoperative pain management. Two pivotal Pha...
MetaVia’s DA-1726 Delivers Rapid, Statistically Si...
Category : Clinical Trial Update 6 January 2026MetaVia has posted eye-catching Phase 1 data for DA-1726, its dual GLP-1/glucagon agonist, showing f...
ScinoPharm Becomes the First Taiwanese Company to...
Category : Clinical Trial Update 5 January 2026ScinoPharm Taiwan has achieved a historic milestone. The company has secured US FDA approval for Gla...
Latest Newsletter Post
-
MetaVia’s DA-1726 Delivers Rapid, S..
6 January 2026
-
Delova Reports Positive Phase 3 Res..
6 January 2026
-
GenEditBio Secures US FDA IND Clear..
6 January 2026
-
AstraZeneca’s Baxdrostat Shows Stro..
6 January 2026
-
Ascletis Secures FDA IND Clearance..
5 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com